Home

Alessandra Cesano

CIK 1827015 · Chief Medical Officer · last filed 2026-06-15

Alessandra Cesano is a Chief Medical Officer who has filed 20 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for PBYI, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$132.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $603.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$603.8K

Companies

4

Total Filings

20

Lifetime Open-Market Net

-$132.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PBYI Director 68,850 $8.77 $603.8K -$132.2K 7 2026-06-15
ZYME Director — $24.32 — $0 3 2026-01-12
SMMT Director — $15.12 — $0 5 2026-01-06
ESSA Pharma Inc. (EPIX) Delisted Chief Medical Officer — $0.20 — $0 3 2024-03-28

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-15 PBYI Grant (A) +27,000 $0 EDGAR
2026-01-12 ZYME Grant (A) — $0 EDGAR
2026-01-06 SMMT Grant (A) — $0 EDGAR
2025-07-22 PBYI Sell (S) −27,000 -$90.9K EDGAR
2025-07-18 PBYI Notice (144) −27,000 -$90.9K EDGAR
2025-06-17 PBYI Sell (S) −12,150 -$41.3K EDGAR
2025-06-13 PBYI Notice (144) −12,150 -$41.3K EDGAR
2025-06-13 PBYI Grant (A) +27,000 $0 EDGAR
2025-01-06 SMMT Grant (A) — $0 EDGAR
2024-12-12 ZYME Grant (A) — $0 EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.